Skip to main content

Week In Review: Innovent Lands $305 Million Investment From Sanofi; Will Partner Two Candidates In China

Suzhou Innovent Biologics will develop two Sanofi cancer candidates for China use in a complicated deal with money due to each company. Sanofi will initially invest $305 million in Innovent shares.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.